Key Takeaways
- Whether a state permits direct license transfers or requires buyers to acquire the licensed entity shapes the deal structure from the first term sheet. States that prohibit license transfer force entity acquisition, which carries with it the full contingent liability profile of the target.
- Change-of-ownership thresholds as low as five to ten percent beneficial interest require disclosure and suitability review in several states, meaning even minority investments in cannabis operators trigger regulatory filings that must be completed before the investment closes.
- Interim operating agreements allow deals to be signed while regulatory approval is pending, but buyers cannot direct or control operations, and the agreements must be carefully structured to avoid unauthorized transfer of control findings by the licensing agency.
- Local jurisdiction approvals, host community agreements, and community benefit plans are distinct from state licensing conditions and must be tracked and satisfied independently. Failure to manage local consents can block or void state licensing even after state suitability review is complete.
Cannabis M&A is regulated at every level of deal execution. A buyer that structures a purchase agreement around a conventional closing schedule without mapping the state licensing approval timeline risks signing a transaction it cannot close on its intended timeline, operating in a regulatory gray zone during the approval period, or losing a deal to an outside date that runs before the agency acts. The licensing framework differs materially across the eleven states addressed here, and the differences are not superficial: they determine whether the deal can be structured as an asset purchase or must be an entity acquisition, whether a five percent equity stake requires full suitability review, and whether local city council approval must precede or run in parallel with state agency approval.
This sub-article is part of the Cannabis M&A: Navigating State Licensing, Section 280E, and Federal Illegality in Deal Structuring guide. It covers the full spectrum of state license transfer mechanics: whether a state's regime is transferable or non-transferable, how direct transfer and entity acquisition pathways differ in practice, what beneficial ownership thresholds trigger change-of-ownership filings, how suitability and fingerprinting review works across states, what pre-approval operating restrictions govern the period between signing and closing, state-specific timelines and requirements for California, Colorado, Illinois, New York, New Jersey, Florida, Michigan, Nevada, Massachusetts, Ohio, and Arizona, local jurisdiction consents including zoning and buffer overlays, community benefit plans and host community agreements, interim operating agreement structure, and walk-away provisions including regulatory reverse termination fees.
Acquisition Stars advises buyers, sellers, and investors in cannabis M&A transactions across multiple state markets. Nothing in this article constitutes legal advice for any specific transaction.
Why Cannabis Licensing Shapes Deal Structure
In most industries, the legal form of an acquisition, whether asset purchase, stock purchase, or merger, is chosen primarily by the parties based on tax treatment, liability allocation, and administrative convenience. In cannabis, the licensing framework determines the available options before the parties negotiate anything else. A state that issues licenses to individuals or to entities and prohibits transfer of those licenses to a different holder forces buyers to acquire the licensed entity (or its parent) rather than the license itself. A state that permits direct license transfer allows a buyer to purchase specific licensed assets, leave behind the target entity's legacy liabilities, and receive a new license in its own name. Most states fall somewhere between these poles, and some states permit both structures depending on the license type, the scope of the transaction, and the relationship between the buyer and seller.
The licensing framework also determines what regulatory approvals are conditions to closing. In a direct license transfer, the buyer applies for a new license or a transferred license in its own name, submits its principals to suitability review, and receives approval before operating. In an entity acquisition, the buyer acquires ownership of the licensed entity, and the change of ownership itself is the regulatory event that must be pre-approved. The distinction matters for due diligence scope, for representations and warranties in the purchase agreement, and for the design of closing conditions.
Cannabis licensing also affects financing. Most institutional lenders and many private credit providers remain unwilling to make secured loans against cannabis licenses, which are not transferable collateral under most state frameworks and which can be revoked for violations that are unrelated to creditworthiness. Buyers in cannabis M&A often finance transactions through seller notes, equity financing, or cannabis-specialized lenders who understand the regulatory environment and the limitations on collateral. The inability to pledge licenses or licensed premises through conventional secured lending channels compresses the capital structure options available to cannabis acquirers compared to conventional M&A.
Deal counsel must therefore understand the licensing framework of each state in the transaction before term sheet negotiations begin. A buyer that proposes an asset purchase in a non-transferable license state will spend weeks negotiating a structure that the licensing agency will not approve, and a buyer that fails to account for the approval timeline in its outside date will find itself at risk of deal termination precisely when the regulatory process is most active.
Transferable vs. Non-Transferable License Regimes
States differ fundamentally on whether a cannabis license can be transferred from one holder to another as a standalone regulatory event. In a transferable license regime, the license itself is an assignable or transferable permit that can move to a qualified new holder upon agency approval, similar to the transfer of a liquor license or a broadcast license. In a non-transferable regime, the license is personal to the entity or individual that was issued it, and the only way for a buyer to acquire licensed operations is to acquire the entity that holds the license or to apply for a new license covering the same premises.
California, Colorado, Michigan, and Nevada are generally transferable-license states for adult-use and medical cannabis, meaning that a licensed operator can apply to transfer its license to a qualified buyer who meets all ownership and suitability requirements. The transfer application requires the buyer to submit full ownership disclosure, suitability documentation for all principals, and evidence that the proposed licensed premises continues to meet all local and state requirements. The licensed seller's operations continue under the existing license during the transfer review period, subject to pre-approval operating restrictions discussed below.
Illinois, New York, New Jersey, and Florida operate under frameworks that are closer to non-transferable regimes for many license types, requiring entity acquisition or imposing strict conditions on what constitutes a permissible license transfer. Illinois has permitted certain license transfers but imposes ownership caps, social equity conditions, and waiting periods. Florida's vertically integrated license structure means that an OMMU license covers a fully integrated operation, and changes in ownership require pre-approval of all new beneficial owners. Massachusetts requires CCC pre-approval for any ownership change exceeding defined thresholds and does not permit conventional license assignment without agency approval of the new owners.
The distinction between transferable and non-transferable regimes affects not just deal structure but indemnification scope. In an entity acquisition required by a non-transferable state, the buyer acquires the full regulatory history of the licensed entity, including any past violations, consent orders, or compliance conditions. Sellers must provide comprehensive regulatory disclosure, and buyers must conduct deep diligence on the licensed entity's compliance record before execution.
Direct Transfer vs. Entity Acquisition Pathways
Where a state permits direct license transfer, buyers must choose between applying for a license transfer (in which the buyer receives the existing license in its own name after suitability approval) and acquiring the licensed entity (in which the buyer acquires the equity of the entity that holds the license and the change-of-ownership filing is the regulatory event). Each pathway has distinct advantages and risks that must be evaluated in the context of the specific state, license type, and transaction structure.
Direct license transfer is generally preferred by buyers in asset purchase transactions because it allows the buyer to take ownership of the licensed assets without assuming the target entity's historical liabilities, including regulatory violations, tax obligations, and contractual defaults. The buyer applies in its own name, undergoes suitability review, and receives a new license (or a transferred license registered in the buyer's name) following approval. The seller's entity continues to exist and retains any liabilities that are not expressly assumed in the purchase agreement. This liability-limitation benefit is significant in cannabis, where the target entity may have outstanding regulatory compliance matters, contested violations, or legacy financial issues that a buyer would prefer not to inherit.
Entity acquisition is often the only available pathway in non-transferable states and is sometimes preferred by buyers even in transferable states when the target entity has regulatory history that the buyer wants to preserve (such as priority status on license renewals, vested local approvals, or established compliance records) or when the transaction structure requires continuity of the licensed entity for third-party contract or lease assignment reasons. Entity acquisition also avoids the need for a new license application in some states, substituting instead a change-of-ownership filing that may be procedurally simpler if the incoming owners have been previously approved by the relevant state agency.
Tax treatment also influences the choice: a direct license transfer structured as an asset purchase triggers asset-level tax basis step-up for the buyer and potentially ordinary income recognition by the seller on depreciation recapture, while an entity acquisition is typically a stock purchase treated as a capital gain by the seller and providing no step-up in the basis of the entity's assets unless a Section 338(h)(10) election is made. Cannabis-specific tax complexities under Section 280E add further wrinkles that counsel must address in structuring discussions.
Change-of-Ownership Thresholds and Beneficial Owner Rules
Every state with a cannabis licensing framework requires disclosure of all beneficial owners above a specified ownership threshold, and most states require pre-approval of any change in beneficial ownership that exceeds a defined trigger. The threshold percentages vary significantly across states, and the definition of "beneficial ownership" often captures indirect ownership through holding companies, trusts, and management agreements in addition to direct equity interests.
California DCC requires disclosure of all persons with five percent or more direct or indirect ownership interest in a licensed entity, and any change in ownership above five percent triggers a change-of-ownership notification or application depending on the magnitude of the change. Colorado MED requires disclosure of owners with ten percent or more economic interest and requires pre-approval before any change in ownership that would result in a new person crossing the ten percent threshold. Michigan CRA requires disclosure of all owners with ten percent or more beneficial interest, but also captures persons with indirect control regardless of ownership percentage, including key persons with management authority. Nevada CCB requires disclosure of all persons with five percent or greater ownership and imposes suitability review on all applicants above that threshold.
Illinois IDFPR requires disclosure of all beneficial owners with one percent or more interest in certain license types, making it among the most comprehensive disclosure regimes. New York OCM, New Jersey CRC, Massachusetts CCC, and Ohio DCC each have their own threshold and disclosure frameworks, and deal counsel must review the specific regulations applicable to the license type being transferred in each transaction. Florida OMMU requires disclosure of all persons with five percent or greater ownership interest in the licensed operator.
Passive investors who receive warrants, convertible notes, or other instruments that could result in ownership above the threshold upon conversion or exercise must also be disclosed in most states, even before the instrument has been exercised. This requirement affects venture capital and private equity investments in cannabis companies and requires careful structuring of investment instruments to avoid inadvertent change-of-ownership filing obligations that would slow the investment timeline.
Suitability, Background, and Fingerprinting Requirements
All states require background investigation of cannabis license holders and their principals, but the scope, depth, and standards differ considerably. Some states apply strict eligibility criteria under which specified criminal history is automatically disqualifying, while others conduct a holistic suitability analysis in which past conduct is weighed against rehabilitation evidence, time elapsed, and the nature of the offense.
Fingerprinting is required by California, Colorado, Michigan, Nevada, Massachusetts, Ohio, and Arizona, among others, and is processed through the state's criminal justice agency or through the FBI's national fingerprint database. Processing times for fingerprint results can range from two to eight weeks depending on the state and the volume of pending applications. In multi-state transactions, the buyer must coordinate fingerprint submissions for all principals across each state on overlapping timelines, and delays in any one state's fingerprint processing can hold up the entire approval in that jurisdiction.
Financial suitability requirements are a distinct component of the approval process in most states. Applicants must demonstrate adequate capitalization, disclose all sources of funds used in the acquisition, and certify that no undisclosed persons have financial interests in the transaction. States including California, Illinois, and New Jersey scrutinize source-of-funds disclosures carefully given the ongoing federal banking restrictions that create unusual funding patterns in cannabis transactions. Buyers using offshore investment vehicles, complex holding structures, or non-institutional funding sources may face extended review periods or requests for additional documentation.
The practical implication of suitability review timelines is that buyers must initiate the background and fingerprint process as early as possible, ideally concurrent with or immediately following letter of intent execution. Waiting until the purchase agreement is signed to begin suitability submissions adds weeks or months to the critical path and compresses the time available to address any issues that arise in the review process before the outside date.
Pre-Approval Operating Restrictions and Escrow of License Authority
Between the signing of a purchase agreement and the receipt of regulatory approval, the licensed cannabis business continues to operate under the seller's existing license. This interim period creates significant regulatory and legal risk for both parties because the buyer cannot legally direct, manage, or control the operations of the business until approval is received, but the buyer has a strong economic interest in protecting the value of the business it has contracted to purchase.
State regulations generally prohibit the unlicensed exercise of control over a cannabis licensee, and an interim operating arrangement in which the buyer effectively manages or directs the business prior to approval can be characterized as an unauthorized change of ownership that threatens the license itself. California DCC has taken enforcement action against arrangements that regulators viewed as disguised pre-approval transfers of control. Michigan CRA has issued guidance distinguishing permissible management consulting arrangements from prohibited pre-approval management agreements. Colorado MED has historically scrutinized management consulting agreements and financial arrangements that give buyers operational influence before change-of-ownership approval.
The permitted scope of buyer involvement during the interim period typically includes access to financial records and operational data for monitoring purposes, attendance at management meetings as an observer, consent rights over defined categories of material decisions (such as entry into material contracts, capital expenditures above a threshold, or changes in key personnel), and the right to receive regular compliance reports from the seller. These consent rights must be structured carefully to avoid the conclusion that the buyer is exercising operational control: the seller must retain day-to-day management authority, and the buyer's consent rights should be limited to extraordinary decisions rather than ordinary course operations.
Escrow of license authority is a concept used in some state frameworks to describe the regulatory mechanism by which a license is held in a provisional status during a pending transfer review. Not all states have formal escrow mechanisms, but some create de facto escrow periods through provisional approval processes that allow the buyer to begin operating under the license while the full approval is being finalized. Counsel should evaluate whether the relevant state has a provisional or temporary authorization framework that can be used to bridge the gap between application submission and final approval.
State Agency Timing Overview: CA, CO, IL, NY, NJ, FL, MI
California DCC processes change-of-ownership applications under a multi-step review that includes application completeness review, ownership background investigation, financial review, and compliance history review. Full change-of-ownership approvals have historically taken six to twelve months from complete application submission, though DCC has implemented process improvements that have shortened some reviews for previously licensed principals. DCC also conducts premises inspections as part of the approval process if any changes to the licensed premises are proposed in connection with the ownership change.
Colorado MED administers change-of-ownership applications for both retail and medical marijuana licenses. Complete applications for ownership changes involving previously approved MED applicants typically take four to eight months from submission to final approval. MED requires that all new owners submit MED applications including financial disclosures, criminal history affidavits, and residency documentation where applicable. Colorado has a two-year prior residency requirement for retail marijuana licensees that affects out-of-state buyers seeking to acquire Colorado operations directly through entities with Colorado-resident principals.
Illinois IDFPR administers cannabis licensing under the Cannabis Regulation and Tax Act, and ownership change reviews have experienced significant administrative delays due to application volume and the complexity of the social equity review process. Timelines for ownership changes have run eight to eighteen months in some transactions. Illinois also imposes ownership caps on cannabis license holders, meaning that a buyer acquiring Illinois cannabis operations must confirm that the acquisition does not cause it to exceed the per-entity license cap applicable to its license type.
New York OCM is still in its administrative build-out phase, and ownership change timelines are not yet predictable based on established precedent. New Jersey CRC targets 120 days for change-of-ownership reviews but routinely extends that window for complex entity structures or new principals. Florida OMMU processes ownership changes for its vertically integrated licenses and has generally taken three to six months for previously approved principals. Michigan CRA targets 90 to 120 days for previously vetted principals but takes longer for new applicants, and the CRA's pre-qualification process for buyers can materially compress timelines if completed before the transaction is announced.
Additional State-Specific Considerations: NV, MA, OH, AZ
Nevada CCB administers cannabis licensing with a suitability-based review framework. All persons with five percent or more ownership interest must be found suitable by the CCB before they may hold a licensed interest. Nevada's suitability standard is holistic and considers financial integrity, business competence, and good character. CCB has an established track record of processing change-of-ownership applications and has generally completed full reviews within four to nine months for buyers whose principals have no prior Nevada licensing history. Buyers with prior Nevada gaming or cannabis licensing history may benefit from expedited review of previously vetted principals.
Massachusetts CCC administers cannabis licensing under a framework that requires pre-approval of any change in ownership exceeding defined thresholds and mandates ongoing compliance with social equity requirements for social equity license types. CCC also imposes a mandatory economic empowerment priority applicant category that carries transfer restrictions. Massachusetts requires that host community agreements (HCAs) be in place with the relevant municipality for any licensed premises, and any change in the licensed operator may require renegotiation or assignment of the existing HCA. CCC review timelines for full ownership changes have generally run four to ten months.
Ohio DCC administers cannabis licensing under the recently implemented adult-use framework following the 2023 ballot initiative. Ohio's change-of-ownership procedures are still being developed and refined, and counsel must monitor DCC rulemaking for current requirements. Ohio requires background investigation of all persons with five percent or more beneficial interest and conducts fingerprint-based criminal history reviews through the Ohio Bureau of Criminal Investigation.
Arizona DHS administers both medical and adult-use cannabis licensing. Arizona permits license transfers and requires DHS pre-approval of any change in ownership above applicable thresholds. Arizona has historically had relatively efficient change-of-ownership processing compared to California and Illinois, with review periods ranging from three to six months for complete applications. Arizona also permits vertical integration and has a broad range of license types, each with its own transfer and ownership change procedures. The Arizona marijuana industry is governed by both the Arizona Department of Health Services for licensing and local jurisdictions for land use approvals.
Local Jurisdiction Consents and Buffer/Zoning Overlays
State licensing does not preempt local land use authority over cannabis facilities in most states. Cities, counties, and townships retain zoning authority, and cannabis operations are subject to local licensing, zoning approval, and buffer requirements that are separate from and must be satisfied in addition to state licensing. A change in ownership that is approved by the state licensing agency can still be blocked or delayed by local government action, particularly in jurisdictions that treat an ownership change as a new application rather than a transfer of an existing local permit.
Buffer requirements establish minimum distances between cannabis facilities and specified sensitive uses including schools, daycares, parks, religious institutions, and residential zones. The applicable buffer distances vary by state and locality, and the measurement methodology (whether measured from property line to property line, from entrance to nearest point of the sensitive use, or in some other manner) varies as well. A proposed facility relocation or expansion in connection with an ownership change may trigger buffer analysis, and a facility that is legally nonconforming under current buffer rules may lose its nonconforming status if an ownership change is treated as a new application by the local jurisdiction.
Zoning overlays in many municipalities restrict cannabis operations to specific zone districts, require conditional use permits, or impose operating conditions including hours of operation, odor mitigation, security requirements, and signage restrictions. An ownership change that causes the local jurisdiction to reassess compliance with overlay conditions can result in conditions being added to the local permit, public hearings being required, or in extreme cases, local permit denial that blocks the transaction even after state approval.
Buyers in cannabis M&A transactions must conduct detailed local land use due diligence for each licensed premises, including review of the existing local cannabis permit, the conditions attached to that permit, the local jurisdiction's policy on ownership change applications, and any pending zoning changes that could affect the premises. This diligence is often more consequential for deal timelines than state licensing diligence because local processes are less predictable and local officials have broader discretion than state licensing agencies operating under defined statutory standards.
Community Benefit Plans and Host Community Agreements
Host community agreements (HCAs) are contracts between cannabis license applicants and the municipalities in which their licensed premises are located. HCAs are mandatory prerequisites to state licensing in Massachusetts and are used voluntarily or as a local requirement in several other states including Illinois, New Jersey, and some California jurisdictions. HCAs typically require the cannabis operator to pay community impact fees, commit to local hiring preferences, support community programs, and comply with operating conditions specified by the local government.
When a cannabis business is acquired, the existing HCA must be addressed as part of the transaction. Some HCAs are assignable with municipal consent, while others terminate upon a change of ownership and require the buyer to enter into a new HCA with the municipality as a condition to local approval. The terms of a new HCA negotiated in connection with an acquisition may differ materially from the original HCA, including higher community impact fees, expanded local hiring requirements, or new operating conditions. Buyers must assess the existing HCA terms, the municipality's approach to HCA assignment or renegotiation, and the financial impact of any fee or commitment changes.
Community benefit plans are broader commitments that some states and localities require cannabis operators to make as conditions of licensure or of licensing approval, including commitments to support workforce development programs, community organizations, or social equity initiatives. Illinois requires certain licensees to commit to diversity and inclusion plans. New York OCM requires social equity plans and community investment commitments. Massachusetts CCC requires community benefit agreements as part of the licensing process for some applicants.
Deal counsel must review all existing HCAs, community benefit agreements, and social equity commitments in the target's portfolio and assess whether an ownership change triggers renegotiation obligations, new fee obligations, or compliance requirements that were not applicable to the seller. These obligations can affect deal economics substantially in markets where community impact fees are material relative to the business's revenue.
Interim Operating Agreements Between Signing and Approval
Interim operating agreements (IOAs) govern the relationship between buyers and sellers during the period between signing of the purchase agreement and receipt of regulatory approval. The primary purpose of an IOA is to protect the buyer's economic interest in the business it has contracted to acquire while ensuring that the seller retains legal control of operations in compliance with the license conditions. An IOA that grants the buyer too much operational authority risks being characterized by the licensing agency as an unauthorized pre-approval transfer of control, which can jeopardize the license and the underlying transaction.
A well-structured IOA typically addresses the following: the seller's obligation to operate the business in the ordinary course consistent with past practice; the buyer's right to receive regular financial and operational reports; a defined list of material decisions requiring buyer consent (typically covering capital expenditures above a specified threshold, entry into or amendment of material contracts, changes in key management personnel, material changes to compliance programs, and decisions that could affect license conditions); the seller's obligation to maintain all licenses, permits, and regulatory approvals in good standing; and the parties' obligations with respect to communication with the licensing agency during the approval period.
IOAs must be disclosed to the licensing agency in many states, either because disclosure is expressly required or because the arrangement constitutes a material fact that must be disclosed as part of the change-of-ownership application. Undisclosed IOAs that come to the licensing agency's attention through inspection, audit, or complaint can trigger enforcement action. Counsel should review the relevant state agency's guidance on permissible interim arrangements before finalizing IOA terms.
Financial arrangements under an IOA, including management fees, earnest money arrangements, or profit-sharing provisions, must also be evaluated against the state's rules on unlicensed financial participation in cannabis operations. Some states treat any financial arrangement that gives an unlicensed person an economic interest in the cannabis business as an unauthorized financial interest requiring pre-approval. These constraints can limit the parties' ability to design creative interim compensation structures and require that the IOA's financial terms be reviewed by counsel familiar with the relevant state's regulations.
Walk-Away, Outside Dates, and Regulatory Reverse Termination Fees
Cannabis purchase agreements must address what happens if regulatory approval is not received by the scheduled closing date. Unlike conventional M&A agreements where the parties have significant control over the closing timeline, cannabis deals are subject to regulatory timelines that neither party can guarantee. The standard approach is to include an outside date that can be extended if regulatory approval is still pending, combined with a regulatory reverse termination fee that compensates the seller if the buyer fails to obtain approval within the extended period.
Outside dates in cannabis transactions typically start at twelve to eighteen months from signing, with one or more extension options of three to six months each that can be exercised upon payment of an extension fee or additional deposit. The extension right is typically conditioned on the buyer's continued diligent pursuit of regulatory approval and the absence of a disqualifying finding in the suitability review that would make approval impossible. Sellers negotiating outside dates should resist indefinite extension rights and insist on defined maximum extension periods tied to concrete regulatory milestones.
Regulatory reverse termination fees are payments owed by the buyer to the seller if the buyer's failure to obtain regulatory approval (due to the buyer's principals' failure to satisfy suitability requirements) causes the deal to fail. These fees are distinct from standard reverse termination fees for financing failures and are calibrated to compensate the seller for the opportunity cost of taking the business off the market during the approval period. Regulatory reverse termination fees in cannabis transactions typically range from three to eight percent of the purchase price, though the appropriate amount depends on deal size, approval timeline, and the relative risk allocation.
The purchase agreement should also address what happens if the licensing agency denies approval (as opposed to simply delaying it), and whether a denial triggers immediate termination rights or whether the parties have an obligation to appeal or seek reconsideration. Buyers who receive a suitability denial based on criminal history or financial integrity issues generally cannot cure that denial through appeal, and the purchase agreement should provide for immediate termination and payment of the regulatory reverse termination fee in that scenario rather than requiring an extended appeals process that delays the seller's ability to find an alternative buyer.
Frequently Asked Questions
What is the typical approval timeline for cannabis change-of-ownership filings across the top state markets?
Timelines vary substantially by state and transaction type. California DCC typically takes six to twelve months for a full ownership change, though pre-approval application reviews have shortened some timelines. Colorado MED processes complete change-of-ownership applications in four to eight months for established licensees with clean ownership histories. Illinois IDFPR reviews have run eight to eighteen months due to administrative backlog and social equity verification requirements. New York OCM timelines are currently unpredictable given the agency's build-out phase, with some transactions taking over a year for final approval. New Jersey CRC targets 120 days but routinely extends that window for multi-owner or complex entity transactions. Florida OMMU operates under a vertically integrated license model and has generally processed ownership changes in three to six months for previously approved principals. Michigan CRA aims for 90 to 120 days for previously vetted individuals but longer for new applicants. Counsel experienced in each state agency's internal review processes and application requirements can materially compress timelines through pre-filing meetings, complete initial submissions, and proactive document management.
What background history disqualifies a proposed owner from receiving cannabis regulatory approval?
Disqualifying history varies by state but common grounds include felony drug convictions (virtually universal), other felony convictions within specified look-back periods (typically five to ten years), prior cannabis license revocations, financial crimes including fraud, money laundering, or embezzlement, and any conviction involving dishonesty or breach of trust. Some states, including Michigan and Illinois, have narrowed disqualifying drug conviction categories as part of social equity reforms, excluding certain marijuana-related offenses that would have been barred under older rules. States that conduct suitability rather than strict eligibility reviews, including California and Nevada, evaluate the totality of circumstances and may approve individuals with older or minor criminal history. Financial suitability failures, including undisclosed bankruptcy, tax liens, or delinquencies, can also block approval independently of criminal history. Sellers and buyers in cannabis M&A transactions must conduct thorough background due diligence on all proposed beneficial owners before executing definitive agreements, since a disqualifying finding post-signing can trigger regulatory reverse termination rights and delay or kill the deal.
How do multi-state operators structure simultaneous license transfers across multiple states?
Multi-state operators (MSOs) acquiring or divesting operations in several states face the compounding challenge of managing parallel regulatory timelines, each with its own application requirements, suitability standards, and pre-approval operating restrictions. The most common structuring approach is a state-by-state closing model in which each state's license transfer or change-of-ownership approval is treated as a separate condition to closing for that state's assets, while other state transactions close independently as their approvals are received. This avoids an all-or-nothing structure that could collapse the entire deal if one state's approval is delayed or denied. Buyer and seller negotiate outside date provisions on a state-by-state basis, with each state's sub-closing subject to its own outside date and regulatory reverse termination fee. Financing structures must accommodate sequential closings and the potential for interim periods during which the buyer has closed on certain state assets but not others. Some MSO transactions use a master purchase agreement with state-specific schedules and addenda that govern the separate sub-closings, allowing the parties to maintain a unified deal framework while accommodating regulatory differences across jurisdictions.
Is the acquired entity or the seller permitted to continue operating the cannabis business during the regulatory approval period?
Pre-approval operations are generally permitted but subject to state-specific restrictions that vary considerably. Most states allow the licensed entity to continue operating under its existing license while a change-of-ownership or entity transfer application is pending, provided the existing licensee (the seller or the entity being acquired) remains in control and no operational changes are made that would require separate regulatory approval. The buyer typically cannot direct, manage, or control operations prior to approval, and interim operating agreements between the parties must be carefully structured to avoid arrangements that regulators could characterize as an unauthorized transfer of control. States including California, Colorado, and Michigan have relatively clear interim operations frameworks. Others, including New York and New Jersey, are still developing guidance on pre-approval operations in complex transactions. The interim period also affects representations and covenants in the purchase agreement: sellers must covenant to operate in compliance with all license conditions, maintain existing staffing, and avoid material operational changes, while buyers must covenant not to assume control prior to regulatory approval.
How does cannabis M&A intersect with Hart-Scott-Rodino antitrust filings and parallel federal review?
Cannabis transactions that meet the HSR Act size-of-transaction and size-of-person thresholds are subject to mandatory pre-merger notification and waiting period requirements under the HSR Act, administered by the FTC and DOJ Antitrust Division. The federal illegality of cannabis under the Controlled Substances Act does not exempt cannabis transactions from HSR filing requirements, and the FTC has reviewed and cleared cannabis transactions. Parties to a reportable cannabis transaction must manage the HSR waiting period (30 days for standard filings, 15 days for cash tender offers and bankruptcies) in parallel with state cannabis regulatory approval timelines, which are typically much longer. The HSR filing does not require simultaneous approval by state cannabis regulators, but both sets of clearances are typically conditions to closing, and the parties must structure their outside dates and termination rights to account for the different timing. HSR filings for cannabis transactions require disclosure of the assets and revenues associated with the cannabis business, and parties should consult antitrust counsel regarding the appropriate classification of cannabis-related lines of business in the filing.
How would federal rescheduling of cannabis from Schedule I affect state license transfer requirements?
Federal rescheduling of cannabis from Schedule I to Schedule III under the Controlled Substances Act, as proposed by the DEA in 2024, would not directly eliminate or modify state cannabis licensing requirements, which are creatures of state law and state regulatory frameworks independent of federal scheduling. State licensing agencies would continue to require change-of-ownership filings, beneficial ownership disclosure, suitability review, and local jurisdiction approvals under their existing statutory frameworks regardless of federal scheduling status. Rescheduling would, however, potentially affect the banking and financing environment for cannabis transactions, reduce Section 280E tax burdens (since 280E applies only to trafficking in Schedule I or II controlled substances), and may reduce federal enforcement risk that currently constrains certain deal structures. Deal counsel should not assume that rescheduling will simplify state regulatory approval processes: those processes are defined by state legislatures and agencies that have built comprehensive regulatory frameworks over years and are unlikely to modify them based on federal scheduling changes alone.
Can social equity license holders transfer or sell their licenses, and are there restrictions on buyouts of social equity operators?
Social equity license restrictions vary significantly by state and are among the most complex regulatory issues in cannabis M&A. Illinois, California, New York, New Jersey, and Massachusetts each have social equity license categories with transfer restrictions designed to prevent non-social equity investors from acquiring control of licenses issued to social equity applicants shortly after licensure. Illinois prohibits transfer of social equity licenses for a specified period following issuance and imposes community reinvestment obligations on social equity licensees. Massachusetts CCC requires that social equity ownership and control be maintained for a specified period and scrutinizes any ownership changes that would dilute social equity ownership below required thresholds. California DCC has restrictions on transfers of certain equity license types. New York OCM has social equity license categories with limited ownership transfer rights. Acquirers targeting social equity licensed operators must conduct detailed diligence on the license-specific conditions, the applicable transfer restriction period, and the agency's current enforcement posture before structuring any transaction, since a transfer that violates social equity conditions can result in license revocation.
Do local jurisdiction approvals need to be obtained before or after state regulatory approval, and how do the two processes interact?
The sequencing of local and state approvals depends on each state's statutory framework and varies considerably. In California, local authorization (city or county approval) is a prerequisite to state DCC licensing for most license types, so a buyer acquiring an existing licensed operator must ensure that local approval for the ownership change is obtained either concurrently with or prior to the state DCC change-of-ownership approval. Local jurisdictions in California have substantial discretion over whether and how to process ownership change requests, and some jurisdictions require new owner suitability reviews, background checks, and public hearings independent of the DCC process. In Colorado, local jurisdiction approval is also required for many license types and typically runs in parallel with MED review. Michigan allows local and state processes to run concurrently. New Jersey requires local municipal approval as a condition of CRTC licensure. Counsel must map the specific local approval requirements for each licensed premises in a transaction and build those timelines into the deal schedule, since a missed local approval can block state licensing even after state suitability has been cleared.
Related Reading
Counsel for Cannabis License Transfers and M&A
Acquisition Stars advises buyers, sellers, and investors on cannabis M&A transactions across state markets, including change-of-ownership filings, interim operating agreements, local jurisdiction consents, and regulatory reverse termination structures. Submit your transaction details for an initial assessment.
Related Practice Areas
Our attorneys handle M&A transactions and securities matters nationwide. Alex Lubyansky leads every engagement personally.